Scholarlink

<p>Alport syndrome (AS) is a genetic disorder characterized by progressive nephritis, hearing loss, and visual impairment. Quantitative analyses of hearing in AS are rare. We conducted a retrospective chart review of clinical features and longitudinal follow-up of patients with AS, including multiple evaluations of pure-tone audiograms in each individual and examination of the relationships between hearing loss and genetic variants. Twelve AS cases from eight Japanese families were studied: one family had an autosomal dominant <i>COL4A4</i> variant and seven carried X-linked variants in <i>COL4A5</i>; all cases presented with moderate hearing loss. Progression of hearing loss was 0.25, 0.29, 0.57, and 2.60 dB HL/year at 500, 1000, 4000, and 8000&#xa0;Hz, respectively. During follow-up (1–10 years), all families exhibited mid-frequency hearing loss. Hearing loss onset occurred later than renal symptoms in all patients with <i>COL4A5</i> variants, and the <i>COL4A4</i> variant did not cause renal symptoms. Hearing loss severity and age of onset appeared to vary depending on the characteristics of the genetic variants, indicating genotype–phenotype correlations; however, hearing decline was predominantly at high frequencies, regardless of genetic variation. These findings provide valuable insights into genotype–phenotype correlations in AS, particularly regarding hearing loss progression and characteristics.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical features of hearing loss and genotype–phenotype correlations in Alport syndrome caused by COL4A4 or COL4A5 variants

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月15日

查看全文
  • Saeko Matsuzaki,
  • Kiyomitsu Nara,
  • Hideki Mutai,
  • Sayaka Katsunuma,
  • Hirokazu Sakamoto,
  • Mizuki Hirose,
  • Naohiro Wakisaka,
  • Nodoka Adachi,
  • Satoshi Asanuma,
  • Masato Fujioka,
  • Tatsuo Matsunaga

摘要

Alport syndrome (AS) is a genetic disorder characterized by progressive nephritis, hearing loss, and visual impairment. Quantitative analyses of hearing in AS are rare. We conducted a retrospective chart review of clinical features and longitudinal follow-up of patients with AS, including multiple evaluations of pure-tone audiograms in each individual and examination of the relationships between hearing loss and genetic variants. Twelve AS cases from eight Japanese families were studied: one family had an autosomal dominant COL4A4 variant and seven carried X-linked variants in COL4A5; all cases presented with moderate hearing loss. Progression of hearing loss was 0.25, 0.29, 0.57, and 2.60 dB HL/year at 500, 1000, 4000, and 8000 Hz, respectively. During follow-up (1–10 years), all families exhibited mid-frequency hearing loss. Hearing loss onset occurred later than renal symptoms in all patients with COL4A5 variants, and the COL4A4 variant did not cause renal symptoms. Hearing loss severity and age of onset appeared to vary depending on the characteristics of the genetic variants, indicating genotype–phenotype correlations; however, hearing decline was predominantly at high frequencies, regardless of genetic variation. These findings provide valuable insights into genotype–phenotype correlations in AS, particularly regarding hearing loss progression and characteristics.